Urban Rural Comparisons of Polycystic Ovary Syndrome Burden among Adolescent Girls in a Hospital Setting in India

Table 2

It shows the demonstration of association between independent study variables with NIH and Rotterdam criteria (presence of any two or all three elements) of PCOS.

Variables assessed	NIH criteria; % ()		Rotterdam criteria; (presence of any two of the three elements); % ()		Rotterdam criteria; (presence of all of the three elements); % ()
	Yes	No	Yes	No	Yes	No
Age (years)	M = 16; (SD = 2)	M = 17; (SD = 2)	M = 16; (SD = 2)	M = 17; (SD = 2)	M = 16; (SD = 2)	M = 17; (SD = 2)
	P = .016		P = .18		P = .020
Type of family
Nuclear	27% (26)	73% (69)	57% (54)	43% (41)	19% (18)	81% (77)
Joint	16% (5)	84% (26)	42% (13)	58% (18)	16% (5)	84% (26)
	P = .20		P = .12		P = .72
Family Size	M = 5; (SD = 1)	M = 6; (SD = 2)	M = 5; (SD = 2)	M = 6; (SD = 2)	M = 5; (SD = 1)	M = 6; (SD = 2)
	P = .39		P = .60		P = .53
Annual household income (INR)	M = 132903; (SD = 20403)	M = 135821; (SD = 25698)	M = 134794; (SD = 22518)	M = 135465; (SD = 26746)	M = 134000; (SD = 22401)	M = 135349; (SD = 24988)
	P = .56		P = .87		P = .87
Highest education level of participant
≤High school	41% (12)	59% (17)	59% (17)	41% (12)	31% (9)	69% (20)
Intermediate (11th-12th grade)	21% (13)	79% (49)	56% (35)	44% (27)	16% (10)	84% (52)
Some college	17% (6)	83% (29)	43% (15)	57% (20)	11% (4)	89% (31)
	P = .053		P = .34		P = .10
Anthropometric characteristics
BMI (kg/m^2)	M = 22; (SD = 3)	M = 21; (SD = 3)	M = 22; (SD = 3)	M = 21; (SD = 2)	M = 22; (SD = 2)	M = 21; (SD = 3)
	P = .035		P = .51		P = .25
Underweight (< 18.5)	10% (2)	90% (17)	5% (1)	95% (18)	1 (5%)	18 (95%)
Normal (18.5–24.9)	27% (25)	73% (69)	22% (21)	78% (73)	21 (22%)	78% (73)
Overweight (25.0–29.9)	27% (3)	73% (8)	9% (1)	91% (10)	1 (9%)	91% (10)
Obese (30–34.9)	50% (1)	50% (1)		100% (2)		2 (100%)
	P = .29		P = .63		P = .25
Waist-hip ratio	M = .84; (SD = .04)	M = .84; (SD = .03)	M = .84; (SD = .04)	M = .85; (SD = .03)	M = .85 (SD = .03)	M = .84; (SD = .04)
	P = .87		P = .17		P = .17
Weight gain during past 3 months
Yes	42% (14)	58% (19)	88% (29)	12% (4)	36% (12)	64% (21)
No	18% (17)	82% (76)	41% (38)	59% (55)	12% (11)	88% (82)
	P = .006		P < .0001		P = .006
Physical activity, vigorous
Yes	7% (2)	93% (28)	16% (5)	84% (25)	7% (2)	93% (28)
No	30% (29)	70% (67)	65% (62)	35% (34)	22% (21)	78% (75)
	P = .009		P < .0001		P = .06
Menstrual history
Oligomenorrhea or amenorrhea	54% (31)	46% (26)	96% (55)	4% (2)	40% (23)	60% (34)
	P < .0001		P < .0001		P < .0001
Age at menarche (years)	M = 12; (SD = 1)	M = 12; (SD = 1)	M = 12; (SD = 1)	M = 12; (SD = 1)	M = 12; (SD = 1)	M = 12; (SD = 1)
	P = .23		P = .49		P = .23
Complaining of leucorrhoea
Yes	25% (5)	75% (15)	65% (13)	35% (7)	15% (3)	85% (17)
No	24% (26)	76% (80)	51% (54)	49% (52)	19% (20)	81% (106)
	P = .96		P = .24		P = .76
Prolactin (µg/L)	M = 14.6; (SD = 3.3)	M = 14.8; (SD = 3.2)	M = 14.4; (SD = 3.1)	M = 15.1; (SD = 3.4)	M = 14.8; (SD = 3.3)	M = 14.7; (SD = 3.2)
	P = .72		P = .27		P = .84
(ng/dL)	M = 148; (SD = 22)	M = 153; (SD = 23)	M = 151; (SD = 23)	M = 152; (SD = 23)	M = 149; (SD = 21)	M = 152; (SD = 23)
	P = .32		P = .79		P = .51
(µg/dL)	M = 10; (SD = 3)	M = 9; (SD = 6)	M = 9; (SD = 7)	M = 9; (SD = 2)	M = 10; (SD = 2)	M = 9; (SD = 6)
	P = .64		P = .89		P = .61
TSH (µU/mL)	M = 2.6; (SD = 1.6)	M = 2.8; (SD = 1.5)	M = 2.6; (SD = 1.5)	M = 3; (SD = 1.5)	M = 2.6; (SD = 1.6)	M = 2.8; (SD = 1.5)
	P = .53		P = .21		P = .44
Testosterone (pg/mL)	M = 3.9; (SD = 1.5)	M = 1.9; (SD = 1.2)	M = 2.9; (SD = 1.6)	M = 1.8; (SD = 1.2)	M = 3.9; (SD = 1.5)	M = 2.2; (SD = 1.4)
	P < .0001		P < .0001		P < .0001
Hirsutism score	M = 14; (SD = 3)	M = 6; (SD = 5)	M = 10; (SD = 5.2)	M = 6; (SD = 5.3)	M = 13; (SD = 3)	M = 7; (SD = 5.5)
	P < .0001		P < .0001		P < .0001
≤8		100% (66)	25	41		66
>8	52% (31)	48% (29)	70% (42)	30% (18)	23% (38)	77% (37)
	P < .0001		P < .0001		P < .0001
Polycystic ovaries (ultrasound)
Positive	30% (23)	70% (53)	79% (60)	21% (16)	30% (23)	70% (53)
Negative	16% (8)	84% (42)	14% (7)	86% (43)		100% (50)
	P = .06		P < .0001		P < .0001